Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Phil Pang
Age : 45
Public asset : 5,374,437 USD
Country of residence : Unknown
Linked companies : Vir Biotechnology, Inc.

Biography of Phil Pang 
Phil Pang is Chief Medical Officer at Vir Biotechnology, Inc. In his past career Dr. Pang occupied the position of Chief Medical Officer of Riboscience LLC. Dr. Pang received an undergraduate degree from Stanford University, a doctorate from The Trustees of Columbia University in The City of New York and a doctorate from Columbia University College of Physicians & Surgeons.


Current positions of Phil Pang 
Holdings of Phil Pang 
Phil Pang : Personal Network 
Most Read News 
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/22CATHIE WOOD : ARK's Cathie Wood says Wall Street not in a bubble
RE
09/24CATHIE WOOD : Chinese crackdown on bitcoin another blow to Cathie Wood's ARK ETF
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/24ELON MUSK : New semiconductor plants will end global auto chip shortage next year -Tesla's Musk
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/24BARRY DILLER : Stock Futures Weaken After Evergrande Payment Deadline Passes
DJ
More news


© 2021 People and Ownership :   
Phil Pang : Connections 


Latest news about Phil Pang 
07/15VIR BIOTECHNOLOGY : Starts Phase 2 Trial of Combination Therapy for Chronic Hepatitis B
MT
2020FOCUS : Next big COVID-19 treatment may be manufactured antibodies
RE
More news